TSXV - Delayed Quote CAD

Premier Health of America Inc. (PHA.V)

Compare
0.1400 -0.0050 (-3.45%)
At close: 3:56 PM EST
Loading Chart for PHA.V
DELL
  • Previous Close 0.1450
  • Open 0.1400
  • Bid 0.1400 x --
  • Ask 0.1450 x --
  • Day's Range 0.1350 - 0.1450
  • 52 Week Range 0.1100 - 0.6700
  • Volume 127,500
  • Avg. Volume 38,878
  • Market Cap (intraday) 7.772M
  • Beta (5Y Monthly) 0.59
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2200
  • Earnings Date Dec 10, 2024 - Dec 16, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 0.50

Premier Health of America Inc., together with its subsidiaries, engages in the provision of staffing and outsourced service solutions for healthcare needs in Canada. It operates in two segments, Per Diem and Travel Nurse. The company provides temporary or permanent resources, including registered nurses, registered practical nurses, registered therapists, and personal support workers for public and private hospitals, medical clinics, and retirement homes. It also offers health consulting, nursing, and healthcare services in remote communities, as well as provides nursing and assistance services in remote regions; and Code Bleu, an agency to employ staff nurses. The company provides its services through PSweb, a CRM platform. It serves governments, corporations, individuals, public and private hospitals, medical clinics, and retirement homes. The company is headquartered in Blainville, Canada.

www.premierhealthgroup.ca

--

Full Time Employees

September 30

Fiscal Year Ends

Recent News: PHA.V

View More

Performance Overview: PHA.V

Trailing total returns as of 11/7/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

PHA.V
67.44%
S&P/TSX Composite index
18.55%

1-Year Return

PHA.V
63.16%
S&P/TSX Composite index
25.84%

3-Year Return

PHA.V
84.95%
S&P/TSX Composite index
15.80%

5-Year Return

PHA.V
53.33%
S&P/TSX Composite index
48.37%

Compare To: PHA.V

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PHA.V

View More

Valuation Measures

Annual
As of 11/6/2024
  • Market Cap

    8.05M

  • Enterprise Value

    59.29M

  • Trailing P/E

    --

  • Forward P/E

    35.97

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.05

  • Price/Book (mrq)

    1.27

  • Enterprise Value/Revenue

    0.40

  • Enterprise Value/EBITDA

    8.34

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -8.20%

  • Return on Assets (ttm)

    0.89%

  • Return on Equity (ttm)

    -98.37%

  • Revenue (ttm)

    148.14M

  • Net Income Avi to Common (ttm)

    -12.14M

  • Diluted EPS (ttm)

    -0.2200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    535k

  • Total Debt/Equity (mrq)

    819.14%

  • Levered Free Cash Flow (ttm)

    -8.37M

Research Analysis: PHA.V

View More

Company Insights: PHA.V

Research Reports: PHA.V

View More

People Also Watch